Jun 04–07, 2025 | Marriott Marquis Washington, DC, Washington, DC, United States
Scientific Organizers:
Rino Rappuoli, Kanta Subbarao, Laurence Zitvogel, and Firdausi Qadri

-
Scientific Organizers: Rino Rappuoli, Kanta Subbarao, Laurence Zitvogel, and Firdausi Qadri
Rino Rappuoli
Kanta Subbarao
Laurence Zitvogel
Firdausi Qadri
***Meeting program subject to change.
Available Formats: = Livestream = In Person = On DemandFundraising
Merchandise Options
Registration Options
Wednesday, June 4, 2025
Booking Function
Thursday, June 5, 2025
Session Chair
Vaccines and Immunizations in a Time of Global Boiling, Megacities, and Antiscience
Comparative Responses to mRNA and Adjuvanted Vaccines
B Cell Responses to mRNA Vaccination/Induction of New Epitopes
Early Immune Responses to Vaccination
Short Talk: Distinct Components of Nucleoside-modified Messenger RNA Vaccines Cooperate to Instruct Efficient T Follicular Helper Cell Responses
Session Chair
Session Chair
Remote Presentation: Structural Characterization of Antibodies for Synergistic HCMV Neutralization
Alumina-coated Microparticles Enable Extended Antigen Delivery of HIV Immunogens in a Single Shot
Isolation of Monoclonal Antibodies against H5Nx Influenza Viruses from Individuals Immunized with a Monovalent H5N1 Vaccine
Computationally Designed mRNA-launched Protein Nanoparticle Immunogens as an Integrated Vaccine Platform
Understanding the Immune Landscape behind TLR-based Hydrogel Vaccines
Tailoring SARS-CoV-2 Humoral Responses using mRNA-encoded mAbs
CyaA Vector Carrying Fragments of the Pneumococcal Surface Protein A as a Vaccine Candidate against Streptococcus Pneumoniae
A STING-Adjuvanted Outer Membrane Vesicle Nanoparticle Vaccine Against Klebsiella pneumoniae
Session Chair
Personalized Cancer Vaccines: Updates and Encouraging Results
Combining Checkpoints Inhibitor Immunotherapy and Personalized Vaccines
Defining TRM Cell Fate: The Combined Influence of TCR Signaling and Tissue Instruction
Short Talk: Systemic STING Nanovaccine for HPV-Induced Cancer Therapy
Short Talk: Enhancing Pancreatic Cancer Vaccines with OX40 Agonist and PD-1 Inhibitor to Synergize Antitumor Immunity and Reshape the Immune Microenvironment
Friday, June 6, 2025
Session Chair
Remote Presentation: Views from the African Continent
WHO Strategy, One Health Considerations, Equity
Prototype Vaccines
An Institute for Pandemic Preparedness
Short Talk: A Mosaic Nanoparticle Displaying Stabilized Stem Trimers of Multiple Hemagglutinin Subtypes Elicits Broadly Cross-Reactive and Protective Immunity in Nonhuman Primates
Short Talk: Machine Learning Enabled Conformational Mapping Optimizes Lassa Virus Vaccine Candidates
Head, B cell Lab
Associate Professor
Principal Scientist
Senior Scientific Editor
Panel Moderator
Panelist
Panelist
Panelist
Germinal Center Selection
B Cell Responses
Short Talk: Heterologous Prime-pull Immunization Strategies for SARS-CoV-2 Drives Enhanced, Long-lived Mucosal and Systemic Cellular and Antibody Responses
Short Talk: Convergent and Clonotype-enriched Mutations Drive Affinity Maturation of a Public Antibody
Saturday, June 7, 2025
Structure Based Design
NIAID Vaccine Adjuvant Program and New Trends in Adjuvant Research
Mechanistic and Non Mechanistic Correlates of Protection
Development of Broadly Protective Vaccines to Antigenically Variable Viruses
The Identification and Validation of Conserved T Cell Epitope Regions in Viral Pathogen Families with Pandemic Potential
Short Talk: Development and Validation of Pan-Betacoronavirus Vaccine Candidates that Target the S2 Domain of Spike
Session Chair
Session Chair
An Influenza HA-expressing mRNA-LNP vaccine induces potent and protective responses in newborn NHP
Antibody Responses to Pneumoviruses Fluctuate During Life – Implications for RSV Vaccination
Protection in Rhesus Macaques Against Schistosoma Mansoni Induced by a Multi-Epitope Vaccine Candidate
Assessment of the Functional Role of Purified Antibodies from Asymptomatic P. vivax-infected Individuals from the Peruvian Amazon using P. Knowlesi in vitro Culture Model
Characterization of Neutralizing Versus Binding Antibody and T Cell Responses to Varicellar-zoster Virus in the Elderly
Structural Basis for Antibody Cross-neutralization of Dengue and Zika Viruses
Reactogenicity to mRNA Vaccines is Linked to Heightened Inflammatory Responses Driven by Vaccine-specific Antibody Responses and Host-intrinsic Factors
Functional, Immunogenetic, and Structural Convergence in Influenza Immunity between Humans and Macaques
CD4+ T Cell Responses to Vaccination in People with HIV Correlate with Risk of COVID-19 in the CoVPN 3008 Clinical Trial
Intranasal Dendritic Cell-targeting Vaccine Booster Elicits Cross-clade, Durable and Protective Systemic and Mucosal Immunity against Sarbecoviruses.
Immunogenicity and Efficacy of Vaccines against Crimean-Congo Hemorrhagic Fever Virus Based on Mopevac, a New Live-Attenuated Virus Vaccine Platform
Immune Control of Host Physiology
Gut Microbiota Impacts the Immunogenicity of Vaccines
Clinical Trials for Intranasal and Aerosol SARS-CoV-2 Vaccine Development
Short Talk: Adjuvant As01 Activates an Innate Immune Cascade in Human Lymph Node Explants, Initiated by Subcapsular Sinus-Lining Macrophages, in an Age-Independent Manner
Sunday, June 8, 2025
Subscribe for Updates